Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1995 Mar;87(3):209–213.

Severe anemia: a risk factor for glomerular injury in sickle cell disease.

M Faulkner 1, E A Turner 1, J Deus 1, K Phillips 1, C Weaver 1, O Taiwo 1, O Omitowoju 1
PMCID: PMC2607821  PMID: 7731071

Abstract

Approximately 15% to 20% of patients with sickle cell disease have proteinuria. Proteinuria, particularly albuminuria, is the hallmark of glomerular injury. This study examines risk factors for glomerular injury as indicated by urinary albumin excretion (UAE) 30 microgram/minute, directly related to sickle cell disease. A total of seven patients were enrolled between September 1992 and March 1993. Fasting blood chemistries, complete blood cell count, 24-hour urine for protein and creatinine clearance, and glomerular filtration rate determined by 125 I-iothalamate were obtained for each patient. The results indicated that the lower the hematocrit, the higher the UAE rate. Low hematocrits have served as a protective mechanism in sickle cell disease by reducing blood viscosity and thus decreasing the number of vaso-occlusive crises. However, severe anemia appears to have an indirect adverse effect on the kidney in sickle cell disease.

Full text

PDF
209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexanian R. Erythropoietin excretion in bone marrow failure and hemolytic anemia. J Lab Clin Med. 1973 Sep;82(3):438–445. [PubMed] [Google Scholar]
  2. Aoki R. Y., Saad S. T. Microalbuminuria in sickle cell disease. Braz J Med Biol Res. 1990;23(11):1103–1106. [PubMed] [Google Scholar]
  3. Bourke E. The kidney in sickle cell anemia. J Assoc Acad Minor Phys. 1992;3(2):41–45. [PubMed] [Google Scholar]
  4. Cruz I. A., Hosten A. O., Dillard M. G., Castro O. L. Advanced renal failure in patients with sickle cell anemia: clinical course and prognosis. J Natl Med Assoc. 1982 Nov;74(11):1103–1109. [PMC free article] [PubMed] [Google Scholar]
  5. Eaton W. A., Hofrichter J., Ross P. D. Editorial: Delay time of gelation: a possible determinant of clinical severity in sickle cell disease. Blood. 1976 Apr;47(4):621–627. [PubMed] [Google Scholar]
  6. Falk R. J., Scheinman J., Phillips G., Orringer E., Johnson A., Jennette J. C. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med. 1992 Apr 2;326(14):910–915. doi: 10.1056/NEJM199204023261402. [DOI] [PubMed] [Google Scholar]
  7. HENDERSON A. B. Sickle cell anemia; clinical study of fifty-four cases. Am J Med. 1950 Dec;9(6):757–765. doi: 10.1016/0002-9343(50)90291-9. [DOI] [PubMed] [Google Scholar]
  8. Klahr S., Schreiner G., Ichikawa I. The progression of renal disease. N Engl J Med. 1988 Jun 23;318(25):1657–1666. doi: 10.1056/NEJM198806233182505. [DOI] [PubMed] [Google Scholar]
  9. McCall I. W., Moule N., Desai P., Serjeant G. R. Urographic findings in homozygous sickle cell disease. Radiology. 1978 Jan;126(1):99–104. doi: 10.1148/126.1.99. [DOI] [PubMed] [Google Scholar]
  10. Morgan A. G., Serjeant G. R. Renal function in patients over 40 with homozygous sickle-cell disease. Br Med J (Clin Res Ed) 1981 Apr 11;282(6271):1181–1183. doi: 10.1136/bmj.282.6271.1181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Morgan A. G., Shah D. J., Williams W. Renal pathology in adults over 40 with sickle-cell disease. West Indian Med J. 1987 Dec;36(4):241–250. [PubMed] [Google Scholar]
  12. Ott N. T. A simple technique for estimating glomerular filtration rate with subcutaneous injection of (125I)lothalamate. Mayo Clin Proc. 1975 Nov;50(11):664–668. [PubMed] [Google Scholar]
  13. PERUTZ M. F., MITCHISON J. M. State of haemoglobin in sickle-cell anaemia. Nature. 1950 Oct 21;166(4225):677–679. doi: 10.1038/166677a0. [DOI] [PubMed] [Google Scholar]
  14. Powars D. R., Elliott-Mills D. D., Chan L., Niland J., Hiti A. L., Opas L. M., Johnson C. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med. 1991 Oct 15;115(8):614–620. doi: 10.7326/0003-4819-115-8-614. [DOI] [PubMed] [Google Scholar]
  15. Powars D. R. Sickle cell anemia: beta s-gene-cluster haplotypes as prognostic indicators of vital organ failure. Semin Hematol. 1991 Jul;28(3):202–208. [PubMed] [Google Scholar]
  16. ROSCOE M. H. Anaemia and nitrogen retention in patients with chronic renal failure. Lancet. 1952 Mar 1;1(6705):444–445. doi: 10.1016/s0140-6736(52)91954-5. [DOI] [PubMed] [Google Scholar]
  17. SINGER K., SINGER L. Studies on abnormal hemoglobins. VIII. The gelling phenomenon of sickle cell hemoglobin: its biologic and diagnostic significance. Blood. 1953 Nov;8(11):1008–1023. [PubMed] [Google Scholar]
  18. de Jong P. E., Saleh A. W., de Zeeuw D., Donker A. J., van der Hem G. K., Pratt J. J., Sewrajsingh G. S., Statius van Eps L. W. Urinary prostaglandins in sickle cell nephropathy: a defect in 9-ketoreductase activity? Clin Nephrol. 1984 Oct;22(4):212–213. [PubMed] [Google Scholar]
  19. de Jong P. E., Statius van Eps L. W. Sickle cell nephropathy: new insights into its pathophysiology. Kidney Int. 1985 May;27(5):711–717. doi: 10.1038/ki.1985.70. [DOI] [PubMed] [Google Scholar]
  20. de Klerk G., Rosengarten P. C., Vet R. J., Goudsmit R. Serum erythropoietin (EST) titers in anemia. Blood. 1981 Dec;58(6):1164–1170. [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES